DOK7 anticorps
Aperçu rapide pour DOK7 anticorps (ABIN2719664)
Antigène
Voir toutes DOK7 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Attributs du produit
- Homo sapiens docking protein 7 (DOK7), transcript variant 1
-
Purification
- Purified from mouse ascites fluids by affinity chromatography
-
Immunogène
- Full length human recombinant protein of human DOK7(NP_775931) produced in HEK293T cell.
-
Isotype
- IgG2b
-
-
-
-
Indications d'application
- WB 1:2000, FLOW 1:100,
-
Commentaires
-
The concentration of the product may vary between diferrent lots.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5-1.0 mg/mL
-
Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
-
- DOK7 (Docking Protein 7 (DOK7))
-
Autre désignation
- DOK7
-
Sujet
- The protein encoded by this gene is essential for neuromuscular synaptogenesis. The protein functions in aneural activation of muscle-specific receptor kinase, which is required for postsynaptic differentiation, and in the subsequent clustering of the acetylcholine receptor in myotubes. This protein can also induce autophosphorylation of muscle-specific receptor kinase. Mutations in this gene are a cause of familial limb-girdle myasthenia autosomal recessive, which is also known as congenital myasthenic syndrome type 1B. Alternative splicing results in multiple transcript variants.
-
Poids moléculaire
- 52.9 kDa
-
ID gène
- 285489
-
NCBI Accession
- NM_173660
-
HGNC
- 285489
-
Pathways
- Skeletal Muscle Fiber Development
Antigène
-